Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Arterial-Venous Reversal Flow in "No-option" Chronic Limb-threating Ischemia (CLTI) Patients"

NCT06277362 is registered in ClinicalTrials.gov with EndoCore Lab s.r.l. as lead sponsor.

NCT NCT06277362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Arterial-Venous Reversal Flow in "No-option" Chronic Limb-threating Ischemia (CLTI) Patients"
Lead sponsor
EndoCore Lab s.r.l.
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2020
Completion date
December 31, 2028
Enrollment
50 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb-threatening ischemia, diabetic foot, peripheral arterial disease